Examination of efficacy of tolvaptan for chronic congective heart failure complicated with chronic kidney disease.

Trial Profile

Examination of efficacy of tolvaptan for chronic congective heart failure complicated with chronic kidney disease.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2014

At a glance

  • Drugs Tolvaptan (Primary) ; Furosemide
  • Indications Heart failure; Renal failure
  • Focus Therapeutic Use
  • Acronyms TOLVAPTAN study
  • Most Recent Events

    • 24 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top